Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Androstenedione M990002

 

CASRN: 63-05-8

Formula: C19-H26-O2

Synonyms/Common Names

  • 4-Androstene-3,17-dione
  • Androtex

Known Uses

Dietary supplement being used by body builders and other athletes as a male hormone booster; starting material used in the manufacture of various pharmaceutical steroids

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 2 weeks (Topical Application)  (C99024B)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M: 0, 1, 5, 10, 20, OR 50 MG/KG; 5/SEX/SPECIES.
  • 2 weeks (Gavage)  (C99024)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M: 0, 1, 5, 10, 20, OR 50 MG/KG; 5/SEX/SPECIES.
  • 13 weeks (Gavage)  (C99024C)  Completed 
    • Rats: F344/N; Mice: B6C3F1/N
    • Dose: R&M: 0, 1, 5, 10, 20, OR 50 MG/KG; 10/SEX/SPECIES; 5X/WEEK.

Long-Term Carcinogenicity

  • 2 years (Gavage)  (C99024C)  Completed 
    • TR-560 (NIH Number: 10-5901)  (Peer Review Approval 02/25/2009A )
      Toxicology and Carcinogenesis Studies of Androstenedione (CASRN 63-05-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies)
    • Rats: F344/N; Mice: B6C3F1/N
    • Carcinogenesis Results
      • Male Rats Equivocal Evidence 
      • Female Rats Equivocal Evidence 
      • Male Mice Clear Evidence 
      • Female Mice Clear Evidence 
    • Dose: RATS & MALE MICE: 0, 10, 20, OR 50 MG/KG FEMALE MICE: 0, 2, 10, OR 50 MG/KG; 50/SEX/SPECIES.

Special Studies

  • Absorption Disposition Metabolism Elimination (Gavage; in-vitro)  (S0812)  Completed 
    • Male and Female Rats; Male and Female Mice; Male and Female Human (Cell Lines)
  • Absorption Disposition Metabolism Elimination (Gavage; Intravenous; in-vitro)  (S0840)  Completed 
    • Citation: Final Compound Report - August 28, 2007. Compound Report: Disposition of Androstenedione.
    • Male and Female Dog: Beagles; Male Mice: B6C3F1; Human (Cell Lines)
    • Dose: In vivo experiments: Beagle dogs were administered 14C-androstenedione by intravenous (10 mg/kg) and by oral administration (100 mg/kg). In vitro metabolite profiles: In vitro experiments have been performed with androstenedione at 10 and 100 µM incubated using Fischer 344 rat, B6C3F1 mouse, and human hepatocytes..
  • Absorption Disposition Metabolism Elimination (in-vitro)  (S0840)  Completed 
    • Citation: Final Compound Report - August 28, 2007. Compound Report: Disposition of Androstenedione.
    • Male and Female Rats: F344/N
    • Dose: In vivo experiments: Beagle dogs were administered 14C-androstenedione by intravenous (10 mg/kg) and by oral administration (100 mg/kg). In vitro metabolite profiles: In vitro experiments have been performed with androstenedione at 10 and 100 µM incubated using Fischer 344 rat, B6C3F1 mouse, and human hepatocytes..

Genetic Toxicology

  • Micronucleus  (A71952)  Completed 
    • Mice: B6C3F1
    • Male Negative 
    • Female Equivocal 
  • Micronucleus  (A80598)  Completed 
    • Rats: Fischer 344
    • Male Negative 
  • Salmonella  (A21570)  Completed 
    •  Negative 
  • Salmonella  (A53831)  Completed 
    •  Negative